Work

Abstract B039: APEX2 is a synthetic lethal target for RNASEH2B-deleted or BRCA-mutant tumors

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b039

Authors: Antoine Simoneau, Steve Lombardo, Ruthie Swain, Serge Gueroussov, Binzhang Shen, Shangtao Liu, Samuel R. Meier, Gwen Cusing, Ashley H. Choi, Tenzing Khendu, Hannah Stowe, Hsin-Jung Wu, Hongxiang Zhang, Douglas A. Whittington, Yi Yu, Jannik N. Andersen, Teng Teng

Institution: Tango Therapeutics (United States)

Language: English

Topic: DNA Repair Mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444760

Cites:

Cited by: 2

Related to: